Clinical Trial Update: A Study of ZG2001 in Participants With KRAS Mutated Advanced Solid Tumours [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for ZG2001 in KRAS-mutated advanced solid tumors in Phase 1/2 cohorts.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kras Mutation-related Tumors
• Solid Tumor

Drugs mentioned

• ZG2001

Snippet

Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd | Conditions: Solid Tumor, KRAS Mutation-Related Tumors | Phase 1, Phase 2 | Status: UNKNOWN